WallStSmart

Accuray Incorporated (ARAY)vsGE HealthCare Technologies Inc. (GEHC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 5283% more annual revenue ($21.64B vs $401.95M). GEHC leads profitability with a 9.9% profit margin vs -12.2%. GEHC appears more attractively valued with a PEG of 2.25. GEHC earns a higher WallStSmart Score of 66/100 (B-).

ARAY

Hold

37

out of 100

Grade: F

Growth: 2.0Profit: 3.0Value: 4.0Quality: 3.0
Piotroski: 1/9Altman Z: -0.67

GEHC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ARAY0 strengths · Avg: 0/10

No standout strengths identified

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
17.7x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
39.0%8/10

Earnings expanding 39.0% YoY

Areas to Watch

ARAY4 concerns · Avg: 3.0/10
Price/BookValuation
8.8x4/10

Trading at 8.8x book value

Market CapQuality
$16.72M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
29.492/10

Expensive relative to growth rate

GEHC3 concerns · Avg: 3.0/10
PEG RatioValuation
2.254/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ARAY

ARAY has a balanced fundamental profile.

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, EPS Growth.

Bear Case : ARAY

The primary concerns for ARAY are Price/Book, Market Cap, Piotroski F-Score. Debt-to-equity of 2.56 is elevated, increasing financial risk.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

ARAY profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.

ARAY carries more volatility with a beta of 1.42 — expect wider price swings.

GEHC is growing revenue faster at 7.2% — sustainability is the question.

GEHC generates stronger free cash flow (793M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (66/100 vs 37/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accuray Incorporated

HEALTHCARE · MEDICAL DEVICES · USA

Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.

Visit Website →

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?